Interacting Drugs |
Carbidopa-levodopa-entacapone vs Pyridoxine |
Security Level |
 |
Mechanism |
Pyridoxine: May diminish the therapeutic effect of Levodopa. |
Management |
The concomitant use of pyridoxine and levodopa (in the absence of a dopa decarboxylase inhibitor (DDI)) should be avoided. Use of a DDI (e.g., carbidopa) with levodopa will essentially eliminate the risk of this interaction. |
Carbidopa-levodopa-entacapone vs Pyridoxine
Post Review about Carbidopa-levodopa-entacapone vs Pyridoxine Click here to cancel reply.
Other Interactions of Carbidopa-levodopa-entacapone
Other Interactions of Pyridoxine
Latest News
- FDA approves Ruconest for treatment of hereditary angioedema
- FDA recommend against aspirin to prevent First Heart Attacks
- FDA approves Pomalyst (pomalidomide) for advanced multiple myeloma
- FDA approves three new drug treatments for type 2 diabetes
- Long-term consequences of vaginal delivery on the pelvic floor
No comments yet.